A phase I, open label, balanced, randomized, two-period (fasting versus fed), two-sequence, cross-over, single-dose food effect study of P2202 of Piramal Life Sciences Limited, India in healthy, adult, male human subjects.

Trial Profile

A phase I, open label, balanced, randomized, two-period (fasting versus fed), two-sequence, cross-over, single-dose food effect study of P2202 of Piramal Life Sciences Limited, India in healthy, adult, male human subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Aug 2016

At a glance

  • Drugs P 2202 (Primary)
  • Indications Metabolic syndrome
  • Focus Pharmacokinetics
  • Sponsors Piramal Enterprises
  • Most Recent Events

    • 12 Dec 2013 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India.
    • 25 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India.
    • 05 Oct 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top